Published in J Nucl Med on February 01, 1996
Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci (2008) 1.56
Controversies arising from recent FDOPA articles. J Nucl Med (1997) 1.10
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls. Eur J Nucl Med Mol Imaging (2008) 1.08
Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology (2011) 1.06
Relationship of striatal dopamine synthesis capacity to age and cognition. J Neurosci (2008) 1.05
Neuroimaging biomarkers for Parkinson disease: facts and fantasy. Ann Neurol (2014) 0.83
Orbitofrontal (18) F-DOPA Uptake and Movement Preparation in Parkinson's Disease. Parkinsons Dis (2015) 0.75
Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia. JCI Insight (2016) 0.75
Brain (18)F-DOPA PET and cognition in de novo Parkinson's disease. Eur J Nucl Med Mol Imaging (2015) 0.75
Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med (2001) 9.51
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A (2001) 2.21
Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A (1991) 2.20
Functional brain networks in DYT1 dystonia. Ann Neurol (1998) 2.14
Patterns of regional brain activation associated with different forms of motor learning. Brain Res (2000) 2.10
The metabolic topography of parkinsonism. J Cereb Blood Flow Metab (1994) 1.89
Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases. J Neurol Neurosurg Psychiatry (2005) 1.83
Functional correlates of pallidal stimulation for Parkinson's disease. Ann Neurol (2001) 1.65
In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.60
Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry (1999) 1.60
Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain (1997) 1.59
Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain (2007) 1.54
Abnormal metabolic brain networks in Tourette syndrome. Neurology (2011) 1.54
The metabolic topography of normal aging. J Cereb Blood Flow Metab (1996) 1.54
Striatal 18F-dopa uptake: absence of an aging effect. J Cereb Blood Flow Metab (1993) 1.52
Metabolic correlates of levodopa response in Parkinson's disease. Neurology (2001) 1.50
Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease. Hum Brain Mapp (2001) 1.48
Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med (1999) 1.48
Structure and evolution of the compact radio source in NGC 1275. Proc Natl Acad Sci U S A (1995) 1.47
Regional metabolism in primary torsion dystonia: effects of penetrance and genotype. Neurology (2004) 1.46
Abnormal structure-function relationships in hereditary dystonia. Neuroscience (2009) 1.45
Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology (2008) 1.45
Thrombotic cerebral vasculopathy associated with herpes zoster. Ann Neurol (1986) 1.45
Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology (1993) 1.44
Differences in cerebral blood flow and glucose utilization in vegetative versus locked-in patients. Ann Neurol (1987) 1.42
The metabolic topography of essential blepharospasm: a focal dystonia with general implications. Neurology (2000) 1.42
FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage (2005) 1.40
Cognitive functioning after pallidotomy for refractory Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 1.40
Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology (2005) 1.38
Stereotactic ventral pallidotomy for Parkinson's disease. Neurology (1995) 1.33
Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry (2000) 1.33
Inferior parietal lobule. Divergent architectonic asymmetries in the human brain. Arch Neurol (1984) 1.29
Transient kinetics of Ca2+ transport of sarcoplasmic reticulum. A comparison of cardiac and skeletal muscle. J Biol Chem (1978) 1.29
Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology (1986) 1.27
Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. J Nucl Med (2001) 1.25
Popliteal vein aneurysm with recurrent pulmonary thromboemboli. JAMA (1976) 1.25
Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med (1998) 1.24
Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia. Neurology (2009) 1.18
Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease. Parkinsonism Relat Disord (2008) 1.16
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography. Neurology (1995) 1.16
Development of a criteria set and a structured interview for disorders of extreme stress (SIDES). J Trauma Stress (1997) 1.14
Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain (2001) 1.13
The metabolic pathology of the AIDS dementia complex. Ann Neurol (1987) 1.11
Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study. Synapse (2002) 1.11
Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. J Nucl Med (1995) 1.11
Combined FDOPA and 3OMFD PET studies in Parkinson's disease. J Nucl Med (1996) 1.11
Posttraumatic stress disorder in mothers of pediatric cancer survivors. Psychosomatics (1996) 1.08
Do static cystourethrograms have a role in the investigation of female incontinence? Am J Obstet Gynecol (1978) 1.07
Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. Arch Neurol (1990) 1.07
Effects of levodopa on motor sequence learning in Parkinson's disease. Neurology (2003) 1.07